Guardant Health (NASDAQ: GH) reported Q3 EPS of ($0.67), $0.30 better than the analyst estimate of ($0.97). Revenue for the quarter came in at $143 million versus the consensus estimate of $137.35 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.